| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 7.89e-09 | 20 | 158 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.93e-07 | 53 | 158 | 7 | GO:0016859 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 3.57e-07 | 36 | 158 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 ARFGEF1 RALGAPA2 ANKRD27 IQGAP1 RGPD3 PLXNB1 RGPD5 | 2.36e-06 | 279 | 158 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.66e-06 | 50 | 158 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | NPR1 PRLHR OR4A47 OR1S1 OR1S2 OR52L1 HCAR1 TAAR5 TSHR ADGRV1 F2RL1 ADGRG4 SORCS1 OR2A12 CXCR6 OR52L2P OR4A15 FSHR OR51G1 ADGRE1 ADGRL2 | 6.75e-06 | 884 | 158 | 21 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IL12RB2 NPR1 PRLHR OR4A47 OR1S1 OR1S2 OR52L1 HCAR1 TAAR5 TSHR ADGRV1 F2RL1 ADGRG4 SORCS1 LIFR OR2A12 PTPRG PTPRH CXCR6 OR52L2P OR4A15 TLR1 FSHR OR51G1 ADGRE1 ADGRL2 PLXNB1 | 7.56e-06 | 1353 | 158 | 27 | GO:0004888 |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 KNTC1 RGPD2 RANBP2 RGPD8 MYO1C TNPO2 RGPD1 ANKRD27 IQGAP1 RGPD3 AKAP13 | 9.84e-06 | 321 | 158 | 12 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 KNTC1 RGPD2 RANBP2 RGPD8 MYO1C TNPO2 RGPD1 ANKRD27 IQGAP1 RGPD3 AKAP13 | 3.06e-05 | 360 | 158 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 ARFGEF2 ARFGEF1 RALGAPA2 ANKRD27 IQGAP1 RGPD3 AKAP13 PLXNB1 RGPD5 | 5.26e-05 | 507 | 158 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 ARFGEF2 ARFGEF1 RALGAPA2 ANKRD27 IQGAP1 RGPD3 AKAP13 PLXNB1 RGPD5 | 5.26e-05 | 507 | 158 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | isomerase activity | 1.49e-04 | 192 | 158 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 5.02e-04 | 20 | 158 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 6.70e-04 | 133 | 158 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 8.76e-04 | 140 | 158 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 9.84e-04 | 25 | 158 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 1.15e-03 | 58 | 158 | 4 | GO:0051018 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC4 MYO1C MYO1D UBA2 TOP6BL DNAH1 DDX46 CHD5 TMEM30A HFM1 KIF4B DNAH9 AQR | 1.22e-03 | 614 | 158 | 13 | GO:0140657 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.40e-11 | 9 | 156 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 3.48e-11 | 10 | 156 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 8.83e-11 | 20 | 156 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.79e-10 | 13 | 156 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 4.85e-10 | 14 | 156 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 3.84e-07 | 38 | 156 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 3.25e-06 | 54 | 156 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 RGPD2 RANBP2 RGPD8 TNPO2 AHCTF1 RGPD1 INPP4B RGPD3 NEMF AKAP13 NUP188 RGPD5 | 6.28e-06 | 378 | 156 | 13 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 RGPD2 RANBP2 RGPD8 TNPO2 AHCTF1 RGPD1 INPP4B RGPD3 NEMF AKAP13 NUP188 RGPD5 | 6.28e-06 | 378 | 156 | 13 | GO:0006913 |
| GeneOntologyBiologicalProcess | nuclear export | 1.19e-05 | 185 | 156 | 9 | GO:0051168 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.48e-05 | 145 | 156 | 8 | GO:0051028 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 1.62e-05 | 71 | 156 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.81e-05 | 195 | 156 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | RGPD4 RGPD2 RANBP2 ABCC4 RGPD8 AHCTF1 RGPD1 SLC35D3 RGPD3 NUP188 | 2.06e-05 | 249 | 156 | 10 | GO:0015931 |
| GeneOntologyBiologicalProcess | import into nucleus | 2.30e-05 | 201 | 156 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 3.45e-05 | 9 | 156 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | RNA transport | 5.71e-05 | 175 | 156 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 5.71e-05 | 175 | 156 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 6.44e-05 | 178 | 156 | 8 | GO:0051236 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 6.61e-05 | 132 | 156 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 7.27e-05 | 134 | 156 | 7 | GO:0010906 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.05e-04 | 191 | 156 | 8 | GO:0007189 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | AKAP6 NPR1 PRLHR OR4A47 OR1S1 OR1S2 OR52L1 HCAR1 TAAR5 TSHR ADGRV1 F2RL1 ADCY6 ADGRG4 SORCS1 OR2A12 CXCR6 OR52L2P OR4A15 FSHR AKAP13 OR51G1 ADGRE1 ADGRL2 | 1.30e-04 | 1395 | 156 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | gluconeogenesis | 2.00e-04 | 111 | 156 | 6 | GO:0006094 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 2.02e-04 | 210 | 156 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 2.37e-04 | 215 | 156 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 2.37e-04 | 215 | 156 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 2.43e-04 | 115 | 156 | 6 | GO:0019319 | |
| GeneOntologyBiologicalProcess | RNA localization | 2.52e-04 | 217 | 156 | 8 | GO:0006403 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 3.19e-04 | 121 | 156 | 6 | GO:0046364 | |
| GeneOntologyBiologicalProcess | negative regulation of toll-like receptor 3 signaling pathway | 3.38e-04 | 4 | 156 | 2 | GO:0034140 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 3.84e-04 | 231 | 156 | 8 | GO:0006109 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 4.69e-12 | 8 | 158 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.47e-11 | 10 | 158 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 4.84e-10 | 14 | 158 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.92e-09 | 18 | 158 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 6.02e-09 | 20 | 158 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 8.37e-09 | 21 | 158 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 7.39e-08 | 101 | 158 | 9 | GO:0005643 | |
| GeneOntologyCellularComponent | inclusion body | 5.45e-06 | 90 | 158 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 3.44e-05 | 9 | 158 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.45e-04 | 14 | 158 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 3.37e-04 | 4 | 158 | 2 | GO:0005853 | |
| GeneOntologyCellularComponent | cell projection membrane | TRPM6 MYO1C MYO1D PKD1L1 ADGRV1 ADCY6 EEF1A1 SLC9C1 KANK1 PTPRH TLN1 | 4.50e-04 | 431 | 158 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | cell cortex | MYO1C MYO1D SPTAN1 STOX1 IQGAP1 EEF1A1 ITPR2 PFN4 AKAP13 EPB42 | 5.37e-04 | 371 | 158 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | stereocilium membrane | 8.35e-04 | 6 | 158 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | cilium | ABCC4 PRLHR DISC1 PKD1L1 ARFGEF2 RSPH6A ADGRV1 ADCY6 CRB1 DNAH1 SLC9C1 TTLL2 TTC21B TSSK4 DNAH9 CFAP46 | 1.30e-03 | 898 | 158 | 16 | GO:0005929 |
| HumanPheno | Abnormal branching pattern of the aortic arch | 1.05e-05 | 33 | 47 | 5 | HP:0011587 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 2.63e-09 | 16 | 120 | 6 | MP:0003701 | |
| MousePheno | failure of blastocyst formation | 6.38e-09 | 31 | 120 | 7 | MP:0012129 | |
| MousePheno | abnormal blastocyst formation | 3.53e-08 | 39 | 120 | 7 | MP:0012128 | |
| MousePheno | abnormal morula morphology | 7.06e-08 | 26 | 120 | 6 | MP:0012058 | |
| MousePheno | decreased tumor latency | 1.77e-07 | 30 | 120 | 6 | MP:0010308 | |
| MousePheno | abnormal tumor latency | 3.90e-07 | 34 | 120 | 6 | MP:0010307 | |
| MousePheno | increased lung carcinoma incidence | 4.60e-06 | 78 | 120 | 7 | MP:0008714 | |
| MousePheno | aneuploidy | 1.33e-05 | 61 | 120 | 6 | MP:0004024 | |
| MousePheno | increased hepatocellular carcinoma incidence | 2.96e-05 | 70 | 120 | 6 | MP:0003331 | |
| MousePheno | increased respiratory system tumor incidence | 3.70e-05 | 107 | 120 | 7 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 3.70e-05 | 107 | 120 | 7 | MP:0008014 | |
| MousePheno | abnormal rod electrophysiology | 7.30e-05 | 119 | 120 | 7 | MP:0004021 | |
| MousePheno | abnormal chromosome number | 9.48e-05 | 86 | 120 | 6 | MP:0004023 | |
| MousePheno | increased incidence of induced tumors | 1.21e-04 | 173 | 120 | 8 | MP:0002021 | |
| MousePheno | abnormal eye electrophysiology | 1.52e-04 | 228 | 120 | 9 | MP:0005551 | |
| MousePheno | increased malignant tumor incidence | 2.03e-04 | 237 | 120 | 9 | MP:0002018 | |
| MousePheno | enlarged epididymis | 2.06e-04 | 99 | 120 | 6 | MP:0004931 | |
| MousePheno | increased incidence of tumors by chemical induction | 2.11e-04 | 141 | 120 | 7 | MP:0004499 | |
| MousePheno | embryonic lethality before implantation | 2.37e-04 | 242 | 120 | 9 | MP:0006204 | |
| MousePheno | increased sarcoma incidence | 2.43e-04 | 102 | 120 | 6 | MP:0002032 | |
| MousePheno | increased carcinoma incidence | 2.95e-04 | 197 | 120 | 8 | MP:0002038 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 3.15e-04 | 107 | 120 | 6 | MP:0003694 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 3.61e-04 | 203 | 120 | 8 | MP:0011094 | |
| MousePheno | increased hepatobiliary system tumor incidence | 3.84e-04 | 111 | 120 | 6 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 3.84e-04 | 111 | 120 | 6 | MP:0008019 | |
| MousePheno | abnormal blastocyst hatching | 4.22e-04 | 113 | 120 | 6 | MP:0003693 | |
| MousePheno | abnormal epididymis morphology | 5.15e-04 | 269 | 120 | 9 | MP:0002631 | |
| MousePheno | abnormal epididymis size | 5.67e-04 | 166 | 120 | 7 | MP:0004926 | |
| Domain | Ran_BP1 | 1.89e-12 | 12 | 156 | 7 | PF00638 | |
| Domain | RANBD1 | 1.89e-12 | 12 | 156 | 7 | PS50196 | |
| Domain | RanBD | 4.08e-12 | 13 | 156 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 4.08e-12 | 13 | 156 | 7 | IPR000156 | |
| Domain | Grip | 1.38e-10 | 11 | 156 | 6 | SM00755 | |
| Domain | GRIP | 1.38e-10 | 11 | 156 | 6 | PF01465 | |
| Domain | GRIP_dom | 2.73e-10 | 12 | 156 | 6 | IPR000237 | |
| Domain | GRIP | 2.73e-10 | 12 | 156 | 6 | PS50913 | |
| Domain | Rab_bind | 7.90e-10 | 7 | 156 | 5 | PF16704 | |
| Domain | GCC2_Rab_bind | 7.90e-10 | 7 | 156 | 5 | IPR032023 | |
| Domain | - | 9.29e-09 | 10 | 156 | 5 | 1.10.220.60 | |
| Domain | ARM-type_fold | USP34 CAND1 UBQLN1 TNPO2 ARFGEF2 ARFGEF1 RALGAPA2 LYST PPP4R4 ITPR2 AP2A1 MROH7 UTP20 NUP188 | 1.01e-06 | 339 | 156 | 14 | IPR016024 |
| Domain | TPR_REGION | RGPD4 RGPD2 RANBP2 RGPD8 TTC39C RGPD1 RGPD3 TTC21B CFAP46 RGPD5 | 1.28e-06 | 165 | 156 | 10 | PS50293 |
| Domain | TPR | RGPD4 RGPD2 RANBP2 RGPD8 TTC39C RGPD1 RGPD3 TTC21B CFAP46 RGPD5 | 1.28e-06 | 165 | 156 | 10 | PS50005 |
| Domain | DUF2012 | 2.27e-06 | 4 | 156 | 3 | PF09430 | |
| Domain | DUF2012 | 2.27e-06 | 4 | 156 | 3 | IPR019008 | |
| Domain | TPR-like_helical_dom | RGPD4 RGPD2 RANBP2 RGPD8 CNOT10 TTC39C RGPD1 RGPD3 TTC21B CFAP46 RGPD5 | 4.28e-06 | 233 | 156 | 11 | IPR011990 |
| Domain | - | RGPD4 RGPD2 RANBP2 RGPD8 CNOT10 TTC39C RGPD1 RGPD3 TTC21B CFAP46 | 9.68e-06 | 207 | 156 | 10 | 1.25.40.10 |
| Domain | GPS | 1.17e-05 | 36 | 156 | 5 | PS50221 | |
| Domain | TPR | 1.28e-05 | 129 | 156 | 8 | SM00028 | |
| Domain | GPS | 1.34e-05 | 37 | 156 | 5 | IPR000203 | |
| Domain | TPR_repeat | 1.60e-05 | 133 | 156 | 8 | IPR019734 | |
| Domain | Carb-bd-like_fold | 3.10e-05 | 8 | 156 | 3 | IPR013784 | |
| Domain | TPR-contain_dom | 3.82e-05 | 150 | 156 | 8 | IPR013026 | |
| Domain | Gonadal | 6.93e-05 | 2 | 156 | 2 | IPR010849 | |
| Domain | Transl_elong_EF1A_euk/arc | 6.93e-05 | 2 | 156 | 2 | IPR004539 | |
| Domain | DGCR6 | 6.93e-05 | 2 | 156 | 2 | PF07324 | |
| Domain | CarboxyPept_regulatory_dom | 1.54e-04 | 13 | 156 | 3 | IPR014766 | |
| Domain | - | 1.54e-04 | 13 | 156 | 3 | 2.60.40.1120 | |
| Domain | GPS | 1.79e-04 | 34 | 156 | 4 | SM00303 | |
| Domain | GPS | 2.00e-04 | 35 | 156 | 4 | PF01825 | |
| Domain | PH_dom-like | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 LYST TLN1 RGPD3 AKAP13 PLD1 DCP1A RGPD5 | 2.48e-04 | 426 | 156 | 12 | IPR011993 |
| Domain | HEAT_REPEAT | 2.98e-04 | 70 | 156 | 5 | PS50077 | |
| Domain | CarboxyPept-like_regulatory | 3.57e-04 | 17 | 156 | 3 | IPR008969 | |
| Domain | DCB_dom | 4.11e-04 | 4 | 156 | 2 | IPR032629 | |
| Domain | Sec7_C | 4.11e-04 | 4 | 156 | 2 | IPR015403 | |
| Domain | DUF1981 | 4.11e-04 | 4 | 156 | 2 | PF09324 | |
| Domain | Sec7_N | 4.11e-04 | 4 | 156 | 2 | IPR032691 | |
| Domain | Sec7_N | 4.11e-04 | 4 | 156 | 2 | PF12783 | |
| Domain | DCB | 4.11e-04 | 4 | 156 | 2 | PF16213 | |
| Domain | - | 5.65e-04 | 222 | 156 | 8 | 1.25.10.10 | |
| Domain | 7tm_2 | 8.00e-04 | 50 | 156 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 8.00e-04 | 50 | 156 | 4 | PS00650 | |
| Domain | TPR_1 | 9.47e-04 | 90 | 156 | 5 | IPR001440 | |
| Domain | TPR_1 | 9.47e-04 | 90 | 156 | 5 | PF00515 | |
| Domain | Gphrmn_rcpt_fam | 1.02e-03 | 6 | 156 | 2 | IPR002131 | |
| Domain | PKD | 1.42e-03 | 7 | 156 | 2 | PF00801 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 1.42e-03 | 7 | 156 | 2 | IPR003529 | |
| Domain | Myosin_TH1 | 1.42e-03 | 7 | 156 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 1.42e-03 | 7 | 156 | 2 | IPR010926 | |
| Domain | TH1 | 1.42e-03 | 7 | 156 | 2 | PS51757 | |
| Domain | GPCR_Rhodpsn_7TM | PRLHR OR4A47 OR1S1 OR1S2 OR52L1 HCAR1 TAAR5 TSHR F2RL1 OR2A12 CXCR6 OR4A15 FSHR OR51G1 | 1.49e-03 | 670 | 156 | 14 | IPR017452 |
| Domain | GPCR_2_secretin-like | 1.59e-03 | 60 | 156 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 1.59e-03 | 60 | 156 | 4 | IPR017981 | |
| Domain | 7tm_1 | PRLHR OR4A47 OR1S1 OR1S2 OR52L1 HCAR1 TAAR5 TSHR F2RL1 OR2A12 CXCR6 OR4A15 FSHR OR51G1 | 1.65e-03 | 677 | 156 | 14 | PF00001 |
| Domain | - | 1.69e-03 | 391 | 156 | 10 | 2.30.29.30 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.69e-03 | 61 | 156 | 4 | PS50261 | |
| Domain | G_PROTEIN_RECEP_F1_1 | PRLHR OR4A47 OR1S1 OR1S2 OR52L1 HCAR1 TAAR5 TSHR F2RL1 OR2A12 CXCR6 OR4A15 FSHR OR51G1 | 1.84e-03 | 685 | 156 | 14 | PS00237 |
| Domain | Transl_elong_EFTu/EF1A_C | 1.88e-03 | 8 | 156 | 2 | IPR004160 | |
| Domain | HEMATOPO_REC_L_F2 | 1.88e-03 | 8 | 156 | 2 | PS01353 | |
| Domain | GTP_EFTU_D3 | 1.88e-03 | 8 | 156 | 2 | PF03143 | |
| Domain | ARM-like | 1.98e-03 | 270 | 156 | 8 | IPR011989 | |
| Domain | P-loop_NTPase | ABCC4 MYO1C MYO1D ARL11 IQGAP1 EEF1A1 DNAH1 EEF1A2 DDX46 NWD2 CHD5 HFM1 KIF4B CARD11 DNAH9 AQR | 1.98e-03 | 848 | 156 | 16 | IPR027417 |
| Domain | G_PROTEIN_RECEP_F1_2 | PRLHR OR4A47 OR1S1 OR1S2 OR52L1 HCAR1 TAAR5 TSHR F2RL1 OR2A12 CXCR6 OR4A15 FSHR OR51G1 | 1.99e-03 | 691 | 156 | 14 | PS50262 |
| Domain | GPCR_Rhodpsn | PRLHR OR4A47 OR1S1 OR1S2 OR52L1 HCAR1 TAAR5 TSHR F2RL1 OR2A12 CXCR6 OR4A15 FSHR OR51G1 | 2.02e-03 | 692 | 156 | 14 | IPR000276 |
| Domain | G_TR_CS | 2.40e-03 | 9 | 156 | 2 | IPR031157 | |
| Domain | PKD/Chitinase_dom | 2.40e-03 | 9 | 156 | 2 | IPR022409 | |
| Domain | PKD | 2.40e-03 | 9 | 156 | 2 | SM00089 | |
| Domain | Ion_trans_dom | 2.70e-03 | 114 | 156 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.70e-03 | 114 | 156 | 5 | PF00520 | |
| Domain | GPCR_2_secretin-like_CS | 2.83e-03 | 34 | 156 | 3 | IPR017983 | |
| Domain | LRR_5 | 2.99e-03 | 10 | 156 | 2 | PF13306 | |
| Domain | LRR_5 | 2.99e-03 | 10 | 156 | 2 | IPR026906 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 2.99e-03 | 10 | 156 | 2 | IPR009001 | |
| Domain | PTPc | 3.33e-03 | 36 | 156 | 3 | SM00194 | |
| Domain | PKD | 3.63e-03 | 11 | 156 | 2 | PS50093 | |
| Domain | PKD_dom | 3.63e-03 | 11 | 156 | 2 | IPR000601 | |
| Domain | PKD_channel | 3.63e-03 | 11 | 156 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 3.63e-03 | 11 | 156 | 2 | IPR013122 | |
| Domain | - | 3.63e-03 | 11 | 156 | 2 | 2.60.40.670 | |
| Domain | TYR_PHOSPHATASE_PTP | 4.19e-03 | 39 | 156 | 3 | PS50055 | |
| Domain | GPCR_2_extracellular_dom | 4.50e-03 | 40 | 156 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 4.50e-03 | 40 | 156 | 3 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 4.50e-03 | 40 | 156 | 3 | PS50227 | |
| Domain | PTPase_domain | 4.83e-03 | 41 | 156 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 4.83e-03 | 41 | 156 | 3 | PF00102 | |
| Domain | G_TR_1 | 5.09e-03 | 13 | 156 | 2 | PS00301 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.91e-03 | 14 | 156 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.91e-03 | 14 | 156 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.91e-03 | 14 | 156 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.91e-03 | 14 | 156 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.91e-03 | 14 | 156 | 2 | IPR011704 | |
| Domain | MT | 5.91e-03 | 14 | 156 | 2 | PF12777 | |
| Domain | AAA_8 | 5.91e-03 | 14 | 156 | 2 | PF12780 | |
| Domain | AAA_5 | 5.91e-03 | 14 | 156 | 2 | PF07728 | |
| Domain | DHC_fam | 6.78e-03 | 15 | 156 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 6.78e-03 | 15 | 156 | 2 | PF03028 | |
| Domain | - | 6.78e-03 | 15 | 156 | 2 | 1.10.1000.11 | |
| Domain | Dynein_heavy_dom | 6.78e-03 | 15 | 156 | 2 | IPR004273 | |
| Domain | Sec7 | 6.78e-03 | 15 | 156 | 2 | PF01369 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 7.09e-11 | 18 | 118 | 7 | MM1549 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.44e-09 | 41 | 118 | 8 | MM15200 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 6.42e-09 | 49 | 118 | 8 | MM14837 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.57e-08 | 40 | 118 | 7 | MM14945 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.10e-08 | 42 | 118 | 7 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 6.04e-08 | 43 | 118 | 7 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.15e-07 | 47 | 118 | 7 | MM14939 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.79e-07 | 50 | 118 | 7 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.05e-07 | 51 | 118 | 7 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.50e-07 | 55 | 118 | 7 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.08e-07 | 58 | 118 | 7 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 5.08e-07 | 58 | 118 | 7 | MM14736 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 5.75e-07 | 117 | 118 | 9 | MM15387 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 9.83e-07 | 92 | 118 | 8 | MM14951 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.12e-06 | 65 | 118 | 7 | MM15147 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.86e-06 | 100 | 118 | 8 | MM14561 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.48e-06 | 73 | 118 | 7 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 5.45e-06 | 82 | 118 | 7 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 6.40e-06 | 84 | 118 | 7 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 7.49e-06 | 86 | 118 | 7 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION | 1.21e-05 | 169 | 118 | 9 | MM14919 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.25e-05 | 129 | 118 | 8 | MM14894 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.38e-05 | 141 | 118 | 8 | MM15266 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | RGPD4 KNTC1 RGPD2 RANBP2 RGPD8 AHCTF1 RGPD1 ANAPC1 RGPD3 NUP188 | 2.67e-05 | 234 | 118 | 10 | MM14898 |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 3.47e-05 | 193 | 118 | 9 | MM14890 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 4.73e-05 | 114 | 118 | 7 | MM15361 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 2.94e-04 | 202 | 118 | 8 | MM15362 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 3.07e-04 | 257 | 118 | 9 | MM14755 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 4.52e-04 | 271 | 118 | 9 | MM15388 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 5.30e-04 | 277 | 118 | 9 | MM15414 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 1.14e-03 | 55 | 118 | 4 | M41823 | |
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 5.79e-14 | 7 | 159 | 6 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 5.79e-14 | 7 | 159 | 6 | 11353387 | |
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 30944974 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 5.79e-14 | 7 | 159 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 5.79e-14 | 7 | 159 | 6 | 17372272 | |
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 38657106 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 21205196 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 18949001 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 25187515 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 8603673 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 26632511 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 24403063 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 23818861 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 23536549 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 12191015 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 22821000 | ||
| Pubmed | 5.79e-14 | 7 | 159 | 6 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.31e-13 | 8 | 159 | 6 | 21670213 | |
| Pubmed | 2.31e-13 | 8 | 159 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.31e-13 | 8 | 159 | 6 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.31e-13 | 8 | 159 | 6 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.31e-13 | 8 | 159 | 6 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 6.90e-13 | 9 | 159 | 6 | 18394993 | |
| Pubmed | 6.90e-13 | 9 | 159 | 6 | 28100513 | ||
| Pubmed | 6.90e-13 | 9 | 159 | 6 | 17887960 | ||
| Pubmed | 6.90e-13 | 9 | 159 | 6 | 11553612 | ||
| Pubmed | 6.90e-13 | 9 | 159 | 6 | 10601307 | ||
| Pubmed | 6.90e-13 | 9 | 159 | 6 | 9733766 | ||
| Pubmed | 6.90e-13 | 9 | 159 | 6 | 28877029 | ||
| Pubmed | 1.72e-12 | 10 | 159 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.72e-12 | 10 | 159 | 6 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.72e-12 | 10 | 159 | 6 | 8857542 | |
| Pubmed | 1.72e-12 | 10 | 159 | 6 | 21859863 | ||
| Pubmed | 3.76e-12 | 11 | 159 | 6 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 3.76e-12 | 11 | 159 | 6 | 35771867 | |
| Pubmed | 3.76e-12 | 11 | 159 | 6 | 34110283 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 6.95e-12 | 38 | 159 | 8 | 12791264 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.39e-11 | 13 | 159 | 6 | 31427429 | |
| Pubmed | 4.02e-11 | 15 | 159 | 6 | 14697343 | ||
| Pubmed | AKAP6 USP34 CAND1 AGO2 EARS2 LAMA5 SNRK ADGRV1 ZZEF1 ANKRD27 WDR43 IQGAP1 DDX46 CHD5 NUP188 ADGRL2 PLXNB1 | 4.08e-10 | 529 | 159 | 17 | 14621295 | |
| Pubmed | 5.83e-10 | 22 | 159 | 6 | 27717094 | ||
| Pubmed | RGPD4 PRPS2 KNTC1 RGPD2 RANBP2 RGPD8 MYO1C MYO1D ADAM7 SPTAN1 RGPD1 STOX1 F2RL1 LYST ADCY6 PPP4R4 IQGAP1 EEF1A1 EEF1A2 AP2A1 CHD5 RGPD3 PCDHGC3 SLC4A11 CFAP46 RGPD5 | 2.24e-09 | 1442 | 159 | 26 | 35575683 | |
| Pubmed | RGPD4 RGPD2 RGPD8 RGPD1 ARFGEF2 ARFGEF1 DDX46 AP2A1 TLN1 RGPD3 RGPD5 | 5.06e-09 | 215 | 159 | 11 | 35973513 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 PRPS2 RGPD2 RANBP2 CAND1 AGO2 RGPD8 MYO1C EARS2 RGPD1 FASTKD5 BIRC6 EEF1A1 NOMO1 EEF1A1P5 EEF1A2 TAF6L NOMO2 ANAPC1 RGPD3 NUP188 NOMO3 RGPD5 | 1.60e-08 | 1257 | 159 | 23 | 37317656 |
| Pubmed | 1.92e-08 | 99 | 159 | 8 | 27746211 | ||
| Pubmed | RANBP2 ABCC4 CAND1 AGO2 MYO1C CNOT10 ARFGEF2 BIRC6 ANKRD27 EEF1A1 NOMO1 ITPR2 AP2A1 CHD5 TMEM30A AKAP13 NUP188 PLD1 SYVN1 AQR STEAP1 DCP1A | 2.04e-08 | 1168 | 159 | 22 | 19946888 | |
| Pubmed | USP34 IL12RB2 AGO2 MYO1C EARS2 AHCTF1 FASTKD5 SRPK2 RALGAPA2 ZZEF1 ADCY6 TAF6L FCSK ANAPC1 ACTR6 CHD5 NUP188 PLD1 ADGRL2 TSSK4 SLC4A11 | 4.47e-08 | 1116 | 159 | 21 | 31753913 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 KNTC1 RGPD2 RANBP2 NPR1 RGPD8 CNOT10 AHCTF1 RGPD1 WDR43 IQGAP1 KANK1 DDX46 AP2A1 ANAPC1 TLN1 RGPD3 KIF4B NUP188 AQR RGPD5 | 7.96e-08 | 1155 | 159 | 21 | 20360068 |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 9.38e-08 | 3 | 159 | 3 | 25576386 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RGPD2 RANBP2 RGPD8 AHCTF1 RGPD1 IQGAP1 TAF6L AP2A1 TLN1 RGPD3 KIF4B | 1.54e-07 | 370 | 159 | 12 | 22922362 |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 2.89e-07 | 31 | 159 | 5 | 19136429 | |
| Pubmed | USP34 RANBP2 MYO1C MYO1D AHCTF1 SPTAN1 BIRC6 WDR43 IQGAP1 DDX46 ANAPC1 TLN1 UTP20 NUP188 AQR | 3.65e-07 | 653 | 159 | 15 | 22586326 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 22084092 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 3.74e-07 | 4 | 159 | 3 | 31833031 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 9480752 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 9267806 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.22e-07 | 202 | 159 | 9 | 33005030 | |
| Pubmed | RGPD4 RGPD2 RANBP2 CAND1 AGO2 RGPD8 SPTAN1 RGPD1 SRPK2 IQGAP1 EEF1A1 EEF1A2 PTPN9 AP2A1 ANAPC1 KCNJ1 RGPD3 KIF4B | 4.87e-07 | 963 | 159 | 18 | 28671696 | |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 6.54e-07 | 156 | 159 | 8 | 30409884 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 RANBP2 RGPD8 MYO1C MYO1D SPTAN1 SRPK2 EEF1A1 EEF1A1P5 ITPR2 AP2A1 RGPD3 KIF4B RGPD5 | 1.25e-06 | 626 | 159 | 14 | 33644029 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TNPO2 DISC1 OR52L1 STOX1 ZZEF1 BIRC6 EEF1A1 EEF1A2 ITPR2 TAF6L TLN1 PIGW UTP20 AKAP13 NUP188 | 1.62e-06 | 736 | 159 | 15 | 29676528 |
| Pubmed | 2.89e-06 | 86 | 159 | 6 | 37253089 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 3.10e-06 | 135 | 159 | 7 | 31077711 | |
| Pubmed | NPR1 UBQLN1 ARFGEF2 LAMA5 ZZEF1 ANKRD27 EEF1A1 NOMO1 KANK1 AP2A1 ZNF107 NOMO3 DCP1A | 3.63e-06 | 591 | 159 | 13 | 15231748 | |
| Pubmed | RGPD4 USP34 RGPD2 NRIP1 RANBP2 RGPD8 RGPD1 BIRC6 ANAPC1 RGPD3 DCP1A | 3.90e-06 | 418 | 159 | 11 | 34709266 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.76e-06 | 271 | 159 | 9 | 32433965 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 5.16e-06 | 8 | 159 | 3 | 15257293 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 5.21e-06 | 146 | 159 | 7 | 23892456 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 7.08e-06 | 153 | 159 | 7 | 26365490 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 7.72e-06 | 9 | 159 | 3 | 36261522 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 KNTC1 RANBP2 CAND1 MYO1C MYO1D SPTAN1 FASTKD5 WDR43 IQGAP1 EEF1A1 NOMO1 AP2A1 ANAPC1 TLN1 NEMF UTP20 NUP188 AQR MCOLN2 | 8.67e-06 | 1425 | 159 | 20 | 30948266 |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 9.14e-06 | 29 | 159 | 4 | 15203201 | |
| Pubmed | 9.93e-06 | 225 | 159 | 8 | 12168954 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 1.03e-05 | 226 | 159 | 8 | 37839992 | |
| Pubmed | 1.06e-05 | 63 | 159 | 5 | 31266804 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.20e-05 | 231 | 159 | 8 | 16452087 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 FOXK2 ARFGEF2 LAMA5 RALGAPA2 ZZEF1 BIRC6 LYST ITPR2 AP2A1 IER5L CHD5 TLN1 PIGW AKAP13 NUP188 SYVN1 | 1.35e-05 | 1105 | 159 | 17 | 35748872 |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.51e-05 | 11 | 159 | 3 | 32820719 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.55e-05 | 33 | 159 | 4 | 25713288 | |
| Pubmed | RANBP2 CAND1 AGO2 UBQLN1 MYO1C MYO1D SPTAN1 SRPK2 IQGAP1 EEF1A1 DNAH1 KANK1 AP2A1 TLN1 NEMF AQR CDK3 DCP1A | 1.74e-05 | 1247 | 159 | 18 | 27684187 | |
| Pubmed | NEPRO RANBP2 FOXK2 CAND1 UBQLN1 CNOT10 AHCTF1 LAMA5 SRPK2 WDR43 IQGAP1 NOMO1 EEF1A1P5 TAF6L DDX46 ANAPC1 TLN1 RGPD3 UTP20 AQR | 1.77e-05 | 1497 | 159 | 20 | 31527615 | |
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 2.08e-05 | 2 | 159 | 2 | 30782564 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 23918382 | ||
| Pubmed | The miRISC component AGO2 has multiple binding sites for Nup358 SUMO-interacting motif. | 2.08e-05 | 2 | 159 | 2 | 33838501 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 19178511 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 17360629 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 10716990 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 25340405 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 35741005 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 18203920 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 18936250 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 9605865 | ||
| Pubmed | The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. | 2.08e-05 | 2 | 159 | 2 | 30370994 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 27410476 | ||
| Pubmed | Force-Dependent Regulation of Talin-KANK1 Complex at Focal Adhesions. | 2.08e-05 | 2 | 159 | 2 | 31389241 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 18417613 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 26212729 | ||
| Interaction | RGPD4 interactions | 1.79e-10 | 22 | 151 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 9.03e-10 | 27 | 151 | 7 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 5.64e-08 | 47 | 151 | 7 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 7.61e-08 | 49 | 151 | 7 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 8.18e-08 | 74 | 151 | 8 | int:RGPD8 | |
| Interaction | RGPD5 interactions | 6.26e-07 | 96 | 151 | 8 | int:RGPD5 | |
| Interaction | NPIPB6 interactions | 8.54e-06 | 18 | 151 | 4 | int:NPIPB6 | |
| Interaction | FER1L6 interactions | 1.41e-05 | 7 | 151 | 3 | int:FER1L6 | |
| Interaction | LRRC31 interactions | 2.48e-05 | 205 | 151 | 9 | int:LRRC31 | |
| Interaction | SLAMF1 interactions | 4.39e-05 | 125 | 151 | 7 | int:SLAMF1 | |
| Interaction | RICTOR interactions | RGPD4 RGPD2 CAND1 RGPD8 MYO1C MYO1D RGPD1 ARFGEF2 ARFGEF1 IQGAP1 EEF1A1 DDX46 AP2A1 PTPRH TLN1 RGPD3 RGPD5 | 5.63e-05 | 759 | 151 | 17 | int:RICTOR |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | RGPD4 RGPD2 RANBP2 RGPD8 CNOT10 TTC39C RGPD1 RGPD3 TTC21B CFAP46 RGPD5 | 1.43e-10 | 115 | 113 | 11 | 769 |
| GeneFamily | Glycoprotein hormone receptors | 1.16e-04 | 3 | 113 | 2 | 199 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 7.72e-04 | 29 | 113 | 3 | 396 | |
| GeneFamily | Nucleoporins | 1.03e-03 | 32 | 113 | 3 | 1051 | |
| GeneFamily | Myosins, class I | 1.06e-03 | 8 | 113 | 2 | 1097 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 3.77e-08 | 33 | 155 | 6 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.97e-07 | 43 | 155 | 6 | MM3857 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 RGPD2 NRIP1 RANBP2 RGPD8 AHCTF1 RGPD1 NOMO1 DNAH1 NOMO2 RGPD3 NOMO3 MCOLN2 RGPD5 | 9.38e-07 | 474 | 155 | 14 | M40991 |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN | 8.49e-06 | 171 | 155 | 8 | M6321 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | KNTC1 IL12RB2 ABCC4 AHCTF1 ARFGEF2 BIRC6 LYST IQGAP1 NOMO2 TMEM30A MCOLN2 | 9.44e-11 | 191 | 158 | 11 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.19e-08 | 185 | 158 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.88e-08 | 191 | 158 | 9 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.43e-07 | 126 | 158 | 7 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.43e-07 | 126 | 158 | 7 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.48e-07 | 186 | 158 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.03e-07 | 200 | 158 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.72e-06 | 192 | 158 | 7 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 5.72e-06 | 192 | 158 | 7 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 5.72e-06 | 192 | 158 | 7 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.72e-06 | 192 | 158 | 7 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.92e-06 | 193 | 158 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | (08)_Brush+PNEC-(0)_Reference|(08)_Brush+PNEC / shred by cell type by condition | 6.77e-06 | 197 | 158 | 7 | d500bfed2a76f7300f2f17b60962c18a40efd084 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.47e-06 | 200 | 158 | 7 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.47e-06 | 200 | 158 | 7 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | E16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.49e-05 | 148 | 158 | 6 | cd5f697d8c2f272be1f3f52a05446749278431c5 | |
| ToppCell | E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.49e-05 | 148 | 158 | 6 | 56e146980a71b5ca655118ae13310c5949220d4a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 160 | 158 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 160 | 158 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-05 | 162 | 158 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 177 | 158 | 6 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.62e-05 | 181 | 158 | 6 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.06e-05 | 184 | 158 | 6 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 185 | 158 | 6 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.53e-05 | 187 | 158 | 6 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-05 | 187 | 158 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.70e-05 | 188 | 158 | 6 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 6.04e-05 | 190 | 158 | 6 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.22e-05 | 191 | 158 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 6.78e-05 | 194 | 158 | 6 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 6.98e-05 | 195 | 158 | 6 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.38e-05 | 197 | 158 | 6 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-05 | 198 | 158 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 7.80e-05 | 199 | 158 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.80e-05 | 199 | 158 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 8.06e-05 | 124 | 158 | 5 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 1.31e-07 | 3 | 151 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | NRIP1 FOXK2 AGO2 MYO1D AVL9 HCAR1 RGPD1 BIRC6 ANKRD27 INPP4B IQGAP1 EEF1A1 EEF1A1P5 PTPRH IER5L AKAP13 HFM1 PLD1 | 1.90e-04 | 1347 | 151 | 18 | EFO_0005192 |
| Disease | proline measurement, amino acid measurement | 2.58e-04 | 5 | 151 | 2 | EFO_0005134, EFO_0009773 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 3.92e-04 | 28 | 151 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | Situs ambiguous | 9.15e-04 | 9 | 151 | 2 | C1167664 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | uric acid measurement | USP34 TSHR TOP6BL ADGRV1 BIRC6 CRB1 SLC15A2 AKAP13 HFM1 ADGRL2 | 1.23e-03 | 610 | 151 | 10 | EFO_0004761 |
| Disease | Situs Inversus | 1.39e-03 | 11 | 151 | 2 | C0037221 | |
| Disease | complement factor H-related protein 3 measurement | 1.81e-03 | 169 | 151 | 5 | EFO_0600056 | |
| Disease | alcohol and nicotine codependence | 1.96e-03 | 13 | 151 | 2 | EFO_0004776 | |
| Disease | Thyroid Diseases | 1.96e-03 | 13 | 151 | 2 | C0040128 | |
| Disease | Situs ambiguus | 2.61e-03 | 15 | 151 | 2 | C0266642 | |
| Disease | Malignant neoplasm of breast | AKAP6 NRIP1 SPTAN1 ARFGEF2 PCDH20 INPP4B SORCS1 KCNJ1 CHD5 MROH7 UTP20 DNAH9 PLXNB1 | 3.59e-03 | 1074 | 151 | 13 | C0006142 |
| Disease | urate measurement, bone density | 4.72e-03 | 619 | 151 | 9 | EFO_0003923, EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILFLKITSSVLHYVV | 11 | P23470 | |
| IGKSAELIYLHAVLA | 391 | Q7Z4L5 | |
| ALHQLDLLQKTIVIY | 296 | Q6UWY0 | |
| GGKLLTNHLKEIISY | 176 | Q9GZN1 | |
| LLLVGLVYLVSHLSQ | 106 | Q96D05 | |
| HYSLLLQVSGRKQLL | 116 | P16452 | |
| QIFSEFLLKLIHILS | 2806 | Q9NR09 | |
| LVLVISIFYHKLQSL | 51 | O00574 | |
| QIKFHVLLTSYELIT | 816 | Q8TDI0 | |
| QFIDTIIKKYGTHLL | 116 | O60477 | |
| IIKKYGTHLLISATL | 121 | O60477 | |
| HQQLILYRLGKTFSI | 96 | Q8IZF6 | |
| GTKVVHFIYIAILSQ | 231 | P43652 | |
| YLKEQHIETFLILGA | 541 | O43306 | |
| IYKTLNIHVTLVGIE | 236 | Q9H2U9 | |
| IKTLITVAHTDGNYL | 1026 | Q9Y6D6 | |
| VHLYELLSALQGVVL | 2526 | Q12802 | |
| ILLIVILKGIYHQSM | 6026 | Q8WXG9 | |
| IKTLITVAHTDGNYL | 971 | Q9Y6D5 | |
| KNAILFETISLIIHY | 306 | O95782 | |
| VDALYHLLSIVKATG | 761 | Q8IYW2 | |
| IAYKDGVHELLLTVI | 836 | O95490 | |
| ILTTYNGQKHLIRDI | 1226 | O60306 | |
| GLLFTSENLKLVHIV | 291 | O76075 | |
| GLLLYIQAVTETLAH | 356 | P16066 | |
| HYQLLSALQSLVKEL | 21 | Q14129 | |
| GLLEIQHLTEKSLYN | 66 | Q14129 | |
| SIDSLSHLKGIYLNL | 536 | Q99467 | |
| FLSTLHEVYLQVLTK | 561 | Q9NPI6 | |
| GKKLLYLEDQLHTAI | 786 | Q9NRI5 | |
| RHLKNTYAGLQLVVV | 506 | Q9UKV8 | |
| YISIGEIINTHTLLL | 1296 | P46940 | |
| SGYLIERHVKNVTLL | 716 | Q9ULI1 | |
| YHQTLEALQTLLKAL | 536 | Q68CQ1 | |
| VFLLGVVYTSHLQLK | 486 | P49792 | |
| YLLLVLSAQQILHVK | 516 | O95072 | |
| LTLLVLLAGYNHDKL | 1166 | P69849 | |
| EVFLLGVVYTSHLQL | 486 | Q99666 | |
| EVFLLGVVYTSHLQL | 486 | O14715 | |
| KSVQHVVLQALFYLL | 121 | P43378 | |
| LGEIVKYSNVIQLLH | 111 | Q14571 | |
| TKLATLNIHDYLTKG | 1186 | Q9H1A4 | |
| TTLLYKLKGHQLVET | 26 | Q969Q4 | |
| FILILSKIYVSLAHV | 556 | Q6IWH7 | |
| VTLLLLHYKASAEVQ | 511 | Q96NW4 | |
| LHALYQAGQLTLILV | 91 | Q86TP1 | |
| LQTDYGLHRLLVKVS | 811 | Q8N6Y1 | |
| LTLLVLLAGYNHDKL | 1166 | Q5JPE7 | |
| GLIIVAISLDTYLHT | 56 | Q8NH92 | |
| SYLHILVAILRIQSG | 216 | Q8NGT7 | |
| ALYDSVILLKHVVLL | 26 | Q92813 | |
| HLIIELYDRGNIVLT | 111 | O60524 | |
| SVSLLELLHIYVGIE | 66 | Q5VWC8 | |
| DKQLTLNGIYTHITK | 276 | Q01167 | |
| LSTIILLGLIIVYHA | 176 | Q9H2S1 | |
| LHTVGLIVQYEGLLS | 656 | O15327 | |
| SQGLKAEHLYILIGV | 156 | Q6GTX8 | |
| KILHYQVTLQELTGG | 356 | Q99665 | |
| LLGSVVYAHSKELIT | 226 | P56696 | |
| QYLLLHSLKEIISSA | 906 | Q86VP6 | |
| YVASLLTVALHGKLE | 1636 | O43157 | |
| TILLSYGVILHSLKT | 241 | Q8NGL6 | |
| LLLISYGVILHSLKN | 211 | Q6IF82 | |
| IYLTVILGNLTILHV | 36 | Q8NGK1 | |
| GYLASIVKNLHLVVL | 76 | Q96PG2 | |
| LTLLVLLAGYNHDKL | 1166 | Q15155 | |
| TGLDHYIERIQKLLA | 821 | Q14678 | |
| VHQDSIVLTYLEGLL | 11 | P48552 | |
| HGTALYQVDLLVKIS | 26 | P50748 | |
| LDLGQVFHVAYVLIK | 146 | O15230 | |
| IYKVLRNVSGQIHLI | 41 | Q8TCA0 | |
| LLLGALNKASTVIHY | 21 | Q9UN70 | |
| ITGTEDVKHYLINIL | 1131 | Q2PPJ7 | |
| ILFVVSGLLHVYQRK | 496 | Q6ZV29 | |
| GLIIVAISLDIYLHT | 56 | Q8NGQ3 | |
| VYLHKITDSVLLKAG | 1041 | A2PYH4 | |
| ITILVTHQLQYLKAA | 586 | O15439 | |
| ENTGVVVVKTHLYLL | 86 | Q8NHR9 | |
| LLVVHYFLIKSQGQS | 306 | P55085 | |
| EVFLLGVVYTSHLQL | 486 | A6NKT7 | |
| LHLIKSYLFQLLQGV | 101 | Q00526 | |
| QKLNDHLLLVYTGKT | 921 | Q8N0W3 | |
| SYLELLHIFSILIGQ | 2806 | Q9P2D7 | |
| LSLSQLVHLIYVIGE | 276 | Q7L8L6 | |
| VSSLLQSILQLYKLH | 1031 | Q9P278 | |
| HALLAYTLGVKQLIV | 136 | Q05639 | |
| HALLAYTLGVKQLIV | 136 | P68104 | |
| LYGLLQAKLQLITHA | 126 | Q8NBF6 | |
| HSGEKLSVLQDYIIL | 71 | Q7Z7B8 | |
| KIITSQNIHLLYLDL | 161 | Q5T5S1 | |
| HYQLLSALQSLVKEL | 21 | Q9BY27 | |
| GLLEIQHLTEKSLYN | 66 | Q9BY27 | |
| SFLLGVVLLVINHKY | 336 | Q9NV96 | |
| LGLIETSLYDNILLH | 2431 | Q99698 | |
| GITIHQSLAIIEYLE | 66 | O43708 | |
| HALLAYTLGVKQLIV | 136 | Q5VTE0 | |
| ALKYLIGELVSSKIH | 866 | Q2VIQ3 | |
| ALVILGTVYLLLENH | 141 | Q9BXC0 | |
| GVTEAAKHSITIYLL | 766 | Q8WYP5 | |
| IYSIILTQHLKLGNF | 2626 | Q9NYC9 | |
| IGIYLLLIASVDIHT | 411 | P23945 | |
| RGLDVKHLILVVNYS | 681 | Q7L014 | |
| VFVKLELLSGYIHLS | 531 | P82279 | |
| YLSLVYVLGHVIKSL | 116 | Q16348 | |
| TYVLQVSVASKHGLL | 1166 | Q8TDX9 | |
| LLDILHTKGQRGYVV | 76 | Q9BXL7 | |
| GGIKLHKNLLVSYVL | 26 | Q5T953 | |
| YRLLQVEISFHLKGI | 216 | Q8IZK6 | |
| LRIADLQGKTSYHLV | 796 | P42702 | |
| LEVFLLGVVYTSHLQ | 476 | P0DJD0 | |
| AIGVSYAHILQAVLK | 231 | Q8NGH7 | |
| AIGVSYAHILQAVLK | 231 | Q8NGH6 | |
| SLYEHLVNLLTKILN | 216 | Q9H0K4 | |
| LTIFIKYVLHSVDLQ | 186 | Q86TM6 | |
| LVSGLYQHILLSLQK | 281 | Q9Y6J9 | |
| RTVHTLGIQLVIYLA | 26 | O14804 | |
| LEIVLKNISHLISAY | 1101 | O75691 | |
| KIIEDLGVHFLLYVL | 1871 | O75691 | |
| LGVHFLLYVLKELQT | 1876 | O75691 | |
| EVFLLGVVYTSHLQL | 486 | Q7Z3J3 | |
| GVLAVLVHAAYLVLI | 161 | Q5M8T2 | |
| RKIHYFTGLQVLQLL | 811 | Q8NBS3 | |
| LLNSGVYLIHKELIT | 426 | Q6NUP7 | |
| VHQLKGLIVLLYSVV | 56 | P49683 | |
| GILHVILIEIDTIKY | 686 | Q4G0N8 | |
| GVYTLLTTHLNAILV | 346 | Q8N6T0 | |
| GNLVTELIYVHSKLL | 886 | Q13393 | |
| VFLLGVVYTSHLQLK | 486 | P0DJD1 | |
| TFLLTVKHLGLQEFI | 156 | Q6NW34 | |
| YTLLINILHSEDLGK | 526 | Q9UBT2 | |
| VIDTQTKLYLILELG | 81 | Q9NRH2 | |
| LVSTAKHLLLYQALG | 251 | Q5JPH6 | |
| RLAIIKSIGYQEHLT | 216 | Q7Z7B1 | |
| HLNISKVLLVLGETY | 161 | Q15399 | |
| HYIQSKLGIVSLLLG | 251 | Q9UHE8 | |
| LKLLSYSVNVIVDIH | 131 | Q13023 | |
| SLYIISHVGIIISLV | 601 | Q14246 | |
| LTYQAEKALHLLAVL | 161 | Q9H9A5 | |
| LTTQKILHTGENLYK | 231 | Q9UII5 | |
| QLTLGIAYLHSKSIV | 131 | Q6SA08 | |
| DVKQHTLLSGYRITL | 496 | Q9BX84 | |
| LGNHLTELETIYVTK | 26 | Q8N8B7 | |
| TIGLLVHFLAVEKTY | 31 | Q86T26 | |
| GYLELLDHVLLTLQK | 2246 | Q9Y490 | |
| LGEITTVLGSHLIYK | 476 | Q6ZVD7 | |
| LILDNKYTEHSTVGL | 2276 | Q13813 | |
| LLSAGATKVYAILTH | 236 | P11908 | |
| SHTDQLVLIFAGKIL | 71 | Q9UMX0 | |
| QHKNLLILYDAIGTL | 531 | O14787 | |
| KSIIRQVLQGLDYLH | 191 | P78362 | |
| LHVSLGQKLVAAYVL | 211 | O75425 | |
| ALHTVQYGLLKILSK | 1546 | Q5SRE5 | |
| LLGYLHFVKIDQETL | 76 | Q14442 | |
| KLVHDIIDLIYLNGL | 406 | Q9BWV7 | |
| ETYHLTLGLLGQLII | 2131 | O43149 | |
| TVVLHQVYNVLLGLL | 2721 | Q70CQ2 | |
| SSVVGLKYLLLGAIH | 481 | Q8N584 | |
| SGHNSSVILILTKLY | 181 | Q8WY21 | |
| TLKELEAGSLYHLTV | 531 | Q9HD43 | |
| ILLYSTVKGELHSKL | 106 | Q15061 | |
| GNVFVLLILLTSHYK | 431 | P16473 | |
| LIGSHIYGKLLKTTV | 221 | P48048 | |
| LIRHQVKYLGLLENL | 641 | O00159 | |
| TVYKILAAILHLGNL | 266 | O94832 |